ADC Therapeutics SA Common Shares

IPO

ADC Therapeutics | Innovating Science. Inspiring Hope.

ADC Therapeutics SA Common Shares is a biotech company in Lausanne, Switzerland, founded in 2011. It has raised $501.0M across 6 rounds, most recently a $276.0M Series E in June 2019.

Headquarters
Lausanne
Employees
201–500
Founded
2011
Business Model
B2B
Total Funding
$501.0M
Last Round
$276.0M Series EJun 2019
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 4 investors for this company. to use credits for reveals, or explore the API.

About

ADC Therapeutics is a commercial-stage oncology company pioneering targeted antibody drug conjugate (ADC) therapies, with its FDA-approved ZYNLONTA (loncastuximab tesirine-lpyl) for relapsed or refractory large B-cell lymphoma. The company is advancing its ADC portfolio into earlier lines of hematologic cancers and solid tumors to address significant unmet medical needs.

Funding & Exit History

Data from Indexed.vcUpdated
IPOMay 2020
$267.0M

6 more events

  • Series E20194 investors
  • Series E20172 investors
  • Series D2016

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ADC Therapeutics SA Common Shares on Indexed.vc
<a href="https://indexed.vc/companies/adc-therapeutics-sa-common-shares"><img src="https://indexed.vc/api/badge/company/adc-therapeutics-sa-common-shares" alt="ADC Therapeutics SA Common Shares on Indexed.vc" width="260" height="76" /></a>